Dice CEO: Energy, T...
BioMarin Pharmaceuticals Inc (BMRN: NASDAQ)
$35.53 -0.11 | -0.31%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 46.27M | 88.08M | 167.17M | 222.90M |
| Receivables | 104.84M | 86.58M | 73.54M | 54.30M |
| Inventories | 130.12M | 109.70M | 78.66M | 73.16M |
| Other Current Assets | 39.75M | 33.87M | 14.85M | 50.44M |
| Total Current Assets | 469.80M | 504.26M | 467.73M | 737.70M |
| Property, Plant & Equipment, Gross | 384.72M | 306.94M | 261.04M | 171.06M |
| Accumulated Depreciation & Depletion | 115.74M | 85.08M | 61.90M | 46.08M |
| Property, Plant & Equipment, Net | 268.97M | 221.87M | 199.14M | 124.98M |
| Intangibles | 180.28M | 103.65M | 40.98M | 7.63M |
| Other Non-Current Assets | 110.44M | 143.47M | 185.60M | 15.13M |
| Total Non-Current Assets | 833.88M | 758.36M | 449.44M | 169.00M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 1.30B | 1.26B | 917.16M | 906.70M |
| Accounts Payable | 94.12M | 83.63M | 78.07M | 58.85M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 70.74M |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 182.00K |
| Total Current Liabilities | 94.12M | 83.84M | 78.15M | 130.08M |
| Long Term Debt | 348.33M | 377.52M | 497.08M | 497.08M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 88.18M | 84.00M | 19.74M | 2.86M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 436.51M | 461.52M | 516.82M | 499.94M |
| Total Liabilities | 530.63M | 545.37M | 594.98M | 630.02M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 773.05M | 717.26M | 322.18M | 276.68M |
| Common Par | 115.00K | 111.00K | 101.00K | 100.00K |
| Additional Paid In Capital | 1.20B | 1.09B | 899.95M | 852.95M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -425.10M | -371.26M | -577.08M | -576.60M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 952.00K | -1.78M | -782.00K | 224.00K |
| Total Capitalization | 1.12B | 1.09B | 819.27M | 773.76M |
| Total Equity | 773.05M | 717.26M | 322.18M | 276.68M |
| Total Liabilities & Stock Equity | 1.30B | 1.26B | 917.16M | 906.70M |
| Total Common Shares Outstanding | 114.79M | 110.63M | 100.96M | 99.95M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 112.12M | 103.09M | 100.27M | 98.98M |
| Diluted Weighted Shares Outstanding | 112.12M | 125.67M | 100.27M | 103.57M |
| Number of Employees | 1002 | 871 | 720 | 649 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with BMRN
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks Rising On Unusual Vo...
- UserScottrade IRA
- UserEverett Bishop Portfolio 1
- ContributorEarnings Short Squeeze Play...
- Userwjwallace Portfolio
- ContributorStocks At New 52-Week Highs...
- ProColumbia Wanger Asset Manag...
- Contributor21 Stocks to Watch
- ContributorBreakout Stocks Of The Week...
Latest BMRN Headlines from TheStreet
- BioMarin Stock Falls On Unusually High Volume (BMRN) 05.31.12 | 02:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.29.12 | 10:05 am
- 8 Stocks Rising on Big Volume 05.21.12 | 01:05 pm
- 5 Stocks Hit 52-Week Highs 05.16.12 | 01:05 pm
- BioMarin Stock Hits New 52-Week High (BMRN) 05.16.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- BioMarin Pharmaceutical's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.27.12 | 03:04 am
- BioMarin Pharmaceutical's CEO Discusses Q4 2011 Earning Results - Earnings Call Transcript 02.16.12 | 11:02 pm
- 5 Earnings Stocks Poised to Pop 02.16.12 | 12:02 pm
- BIO CEO Confab Live Blog: Day 2 02.14.12 | 10:02 am
Press Releases for BMRN
- IU Confidential Publishes Biotech Investment Report - PR Newswire 07.28.11 | 09:07 am
- BioMarin Launches Firdapse In The European Union - PR Newswire 04.19.10 | 09:04 am
- BioMarin To Present At The Barclays Capital Global Healthcare Conference - PR Newswire 03.17.10 | 09:03 am
- BioMarin To Acquire LEAD Therapeutics - PR Newswire 02.04.10 | 04:02 pm
Partner Headlines for BMRN
- BioMarin Prices Share Offering - Analyst Blog - Zacks 06.01.12 | 05:06 pm
- Analyst Insights: Finish Line, BioMarin Pharma, Laboratory Corp, Ocz Technology, AstraZeneca May 31st - Wall St. Cheat Sheet 05.31.12 | 10:05 am
- 9 High-Liquidity Mid Caps Poised For Growth - Seeking Alpha 05.28.12 | 08:05 am
- Loss at BioMarin Wider Than Expected - Analyst Blog - Zacks 02.17.12 | 09:02 am
- Zacks Bull and Bear of the Day Highlights: ProAssurance, BioMarin Pharmaceutical, Diebold, Vodafone and United Parcel Services - Press Releases - Zacks 02.14.12 | 09:02 am
- BioMarin Pharmaceutical (BMRN) - Bear of the Day - Zacks 02.14.12 | 01:02 am
- Zacks #5 Rank Additions for Wednesday - Tale of the Tape - Zacks 02.08.12 | 09:02 am
- BioMarin's Facility Expansion Backed - Analyst Blog - Zacks 12.22.11 | 10:12 am
- Facility Expansion at BioMarin - Analyst Blog - Zacks 11.29.11 | 10:11 am
- Activist Hedge Fund Accipiter Capital's Top Stock Picks - Seeking Alpha 11.29.11 | 09:11 am





